Quantcast


Last updated: October 23. 2013 9:36AM - 181 Views
Associated Press



Story Tools:

Font Size:

Social Media:

(AP) The Food and Drug Administration has issued a positive review for a highly anticipated hepatitis C drug from Gilead Sciences, saying the pill cures more patients in less time than currently available treatments.


The agency posted its review of Gilead's sofosbuvir online ahead of a meeting Friday where government experts will vote on whether to recommend the drug's approval.


More than 3 million people in the U.S. have Hepatitis C, a blood-borne disease that causes liver damage and is blamed for 15,000 deaths a year. The drugs currently used to treat the virus cure about 65 to 75 percent of people and can take up to a year of treatment.


FDA said sofosbuvir cured 90 percent of patients with the most common form of the virus in just 12 weeks.


Associated Press
Comments
comments powered by Disqus



Featured Businesses


Poll



Info Minute



Gas Prices

Wilkes-Barre Gas Prices provided by GasBuddy.com